Inflammatory Bowel Disease (IBD) causes gastrointestinal tract dysregulation and triggers inflammation. Severe inflammatory events often lead to leukocyte infiltration. Yacon is known to have anti-inflammatory properties, making it a potential alternative treatment for colitis.
AIMS:
To investigate colonic Interleukin-23 (IL-23) level and leukocyte infiltration profile in 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-induced colitis mouse model treated with yacon syrup powder.
METHODS:
Thirty male BALB/c mice (5 weeks old, body weight: 30.02±1.28 g) were randomly divided into 6 groups (K1-K6). Intra-rectal administration of TNBS was performed to K2-K6 to make the colitis model. K4-K6 were given yacon syrup powder daily for 14 days with the dose of 0.165, 0.331, and 0.662 g/30 g body weight (BW) respectively. IL-23 levels of colonic tissue were measured using ELISA. Leukocyte infiltration profile was calculated through microscopic observation of histology slides and presented in percentage and degree.
RESULTS:
Significantly different IL-23 levels were observed among the groups (P < 0.001). The percentage and degree of leukocyte infiltration in yacon-treated groups showed a significant decrease compared to colitis groups (P < 0.001).
CONCLUSION:
Yacon syrup powder provides beneficial effects on colitis mice by lowering the IL-23 level and number of leukocytes at the inflammation site.
FreemanK, RyanR, ParsonsN, Taylor-PhillipsS, WillisBH, ClarkeA. The incidence and prevalence of inflammatory bowel disease in UK primary care: a retrospective cohort study of the IQVIA Medical Research Database. BMC Gastroenterol. 2021;21(1):139.
2.
GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30.
3.
JairathV, FeaganBG. Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020;5(1):2–3.
4.
PigneurB, RuemmeleFM. Nutritional interventions for the treatment of IBD: Current evidence and controversies. Therap Adv Gastroenterol. 2019;12:1756284819890534.
5.
SeyedianSS, NokhostinF, MalamirMD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019;12(2):113–22.
6.
KimDH, CheonJH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw. 2017;17(1):25–40.
Alemany-CosmeE, Sáez-GonzálezE, MoretI, MateosB, IborraM, NosP, et al. Oxidative stress in the pathogenesis of crohn’s disease and the interconnection with immunological response, microbiota, external environmental factors, and epigenetics. antioxidants (Basel). 2021;10(1):64.
9.
Cabrera-GarcíaAI, ProtschkaM, KatherS, DenglerF, AlberG, MüllerU, et al. Dysregulation of gastrointestinal rage (receptor for advanced glycation end products) expression in a spontaneous animal model of inflammatory bowel disease. IBD. 2021;27(1):S3.
10.
KanyS, VollrathJT, ReljaB. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20(23):6008.
11.
LiuT, ZhangL, JooD, SunSC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.
12.
KashaniA, SchwartzDA. The expanding role of anti-IL-12 and/or anti-IL-23 antibodies in the treatment of inflammatory bowel disease. Gastroenterol Hepatol (NY). 2019;15(5):255–65.
13.
GermicN, FrangezZ, YousefiS, SimonHU. Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation. Cell Death Differ. 2019;26(4):715–27.
14.
AcharyaD, LiXRL, HeinemanRE, HarrisonRE. Complement receptor-mediated phagocytosis induces proinflammatory cytokine production in murine macrophages. Front Immunol. 2020;10:3049.
15.
BianZ, GuoY, HaB, ZenK, LiuY. Regulation of the inflammatory response enhancing neutrophil infiltration under chronic inflammatory conditions. J Immunol. 2012;188(2):844–53.
16.
SilvaI, PintoR, MateusV. preclinical study in vivo for new pharmacological approaches in inflammatory bowel disease: A systematic review of chronic model of TNBS-induced colitis. J Clin Med. 2019;8(10):1574.
17.
RezendeKS, FernandesMR, de FariaBB, GuimarãesRCA, FreitasKC. Use of Animal Models in the Study of Colitis. Experimental Animal Models of Human Diseases –An Effective Therapeutic Strategy. London: IntechOpen; 2018.
18.
CatanaCS, MagdasC, TabaranFA, CraciunEC, DeakG, MagdaşVA, et al. Comparison of two models of inflammatory bowel disease in rats. Adv Clin Exp Med. 2018;27(5):599–607.
19.
Ganji-ArjenakiM, Rafieian-KopaeiM. Phytotherapies in inflammatory bowel disease. J Res Med Sci. 2019;24:42.
20.
HolleranG, ScaldaferriF, GasbarriniA, CurròD. Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials. Phytother Res. 2020;34(1):77–93.
21.
CaoY, MaZF, ZhangH, JinY, ZhangY, HayfordF. Phytochemical properties and nutrigenomic implications of yacon as potential source of prebiotic current evidence and future direction. Foods. 2018;7(59):1–13.
22.
National Research Council (US)Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th edition. Washington (DC): National Academies Press (US); 2011.
23.
RahmaisyahD,
WasityastutiW,
WidasariDI. Kadar interleukin 23 (IL-23) dan profil infiltrasi leukosit pada kolon mencit model kolitis hasil induksi TNBS (2.4.6-trinitrobenzene sulfonic acid) yang diberi bubuk umbi yakon (Smallanthus sonchifolius). Yogyakarta: ETD UGM Theses and Dissertations Repository; 2019.
24.
SteinhoffU, VisekrunaA. Mucosal immunity and inflammation. Methods in Microbiology. 2010;37:353–67.
25.
GentaSB, CabreraWM, GrauA, SánchezSS. Subchronic 4-month oral toxicity study of dried Smallanthus sonchifolius (yacon) roots as a diet supplement in rats. Food Chem Toxicol. 2005;43(11):1657–65.
26.
PandeyR, DrakoulakisE, AthanasouNA. An assessment of the histological criteria used to diagnose infection in hip revision arthroplasty tissues. J Clin Pathol. 1999;52(2):118–23.
27.
BiggerstaffJ, WeidowB, AmirkhosraviA, FrancisJL. Enumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy. BMC Immunol. 2006;7:16.
28.
ZiaiJ, GilbertHN, ForemanO, Eastham-AndersonJ, ChuF, HuseniM, et al. CD8+T cell infiltration in breast and colon cancer: A histologic and statistical analysis. PLoS One. 2018;13(1):e0190158.
29.
AmehoCK, AdjeiAA, HarrisonEK, TakeshitaK, MoriokaT, ArakakiY, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut. 1997;41(4):487–93.
30.
ErbenU, LoddenkemperC, DoerfelK, SpieckermannS, HallerD, HeimesaatMM, et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7(8):4557–76.
31.
AntoniouE, MargonisGA, AngelouA, PikouliA, ArgiriP, KaravokyrosI, et al. The TNBS-induced colitis animal model: An overview. Ann Med Surg (Lond). 2016;11:9–15.
32.
AlloccaM, FurfaroF, FiorinoG, GilardiD, D’AlessioS, DaneseS. Can IL-23 be a good target for ulcerative colitis?Best Pract Res Clin Gastroenterol. 2018;33:95–102.
33.
FlanniganKL, NgoVL, GeemD, HarusatoA, HirotaSA, ParkosCA, et al. IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria. Mucosal Immunol. 2017;10(3):673–84.
34.
WardillHR, ChooJM, DmochowskaN, MavrangelosC, CampanielloMA, BowenJM, et al. Acute colitis drives tolerance by persistently altering the epithelial barrier and innate and adaptive immunity. Inflamm Bowel Dis. 2019;25(7):1196–207.
35.
MonteiroCEDS, FilhoHBDC, SilvaFGO, de SouzaMDFF, SousaJAO, FrancoAX, et al. Euterpe oleracea Mart. (Açaí) attenuates experimental colitis in rats: involvement of TLR4/COX-2/NF-kB. Inflammopharmacology. 2021;29(1):193–204.
36.
SeldersGS, FetzAE, RadicMZ, BowlinGL. An overview of the role of neutrophils in innate immunity, inflammation, and host-biomaterial integration. Regen Biomater. 2017;4(1):55–68.
37.
KimCK, YangVW, BialkowskaAB. The role of intestinal stem cells in epithelial regeneration following radiation-induced gut injury. Curr Stem Cell Rep. 2017;3(4):320–32.
38.
CastroA, VilaplanaF, NilssonL. Characterization of water soluble, hyperbranched arabinogalactan from yacon (Smallanthus sonchifolius) roots. Food Chem. 2017;223:76–81.
39.
HayenSM, KnulstAC, GarssenJ, OttenHG, WillemsenLEM. Fructo-oligosaccharides modify human DC maturation and peanut-induced autologous T-cell response of allergic patients in vitro. Front Immunol. 2021;11:600125.
40.
LiuF, LiP, ChenM, LuoY, PrabhakarM, ZhengH, et al.Fructooligosaccharide (FOS) and galactooligosaccharide (GOS) increase bifidobacterium but reduce butyrate producing bacteria with adverse glycemic metabolism in healthy young population. Sci Rep. 2017;7(1):11789.
41.
BaxterNT, SchmidtAW, VenkataramanA, KimKS, WaldronC, SchmidtTM. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. mBio. 2019;10(1):e02566–18.
42.
CaoY, MaZF, ZhangH, JinY, ZhangY, HayfordF. Phytochemical properties and nutrigenomic implications of yacon as potential source of prebiotic: Current evidence and future directions. Foods. 2018;7(59).
43.
PereiraJAR, TeixeiraMC, SaczkAA, BarcelosMdFP, de OliveiraMF, AbreuWC. Total antioxidant activity of yacon tubers cultivated in brazil. Ciência e Agrotecnologia. 2016;40(5):596–605.
44.
OhkawaraT, TakedaH, NishihiraJ. Protective effect of chlorogenic acid on the inflammatory damage of pancreas and lung in mice with 1-arginine-induced pancreatitis. Life Sci. 2017;190:91–6.
45.
UmizahLP, WasityastutiW, WidasariDI, SetyoP. Effects of yacon on colonic ifn-γ and goblet cells of 2,4,6-trinitrobenzene sulfonic acid-induced colitis mouse model. Iran Biomed J. 2020;24(5):281–7.
46.
HwangSJ, KimYW, ParkY, LeeHJ, KimKW. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm Res. 2014;63(1):81–90.
47.
GoyalS, RampalR, KediaS, MahajanS, BopannaS, YadavDP, et al. Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role. Sci Rep. 2017;7(1):18068.
48.
KhaliliH, MalikS, AnanthakrishnanAN, GarberJJ, HiguchiLM, JoshiA, et al.Identification and characterization of a novel association between dietary potassium and risk of crohn’s disease and ulcerative colitis. Front Immunol. 2016;7:1–12.
